Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L30 pseudogene 2 (RPL30P2) is a processed pseudogene in the human genome. Pseudogenes like RPL30P2 are remnants of gene duplication or retrotransposition events and do not encode functional proteins. In this case, RPL30P2 is related to the functional RPL30 gene, which encodes a component of the large 60S ribosomal subunit, but RPL30P2 itself is non-functional, lacking introns and often containing frame disruptions or lacking regulatory elements necessary for expression[1][4][6]. There are many ribosomal protein pseudogenes in the human genome due to the high level of gene duplication in ribosomal protein families[4]. These pseudogenes do not play a direct biological role, are not therapeutic targets, and are not associated with disease as primary causes or biomarkers[4][5][6]. Key Points: - RPL30P2 is not a functional protein or receptor; it is a processed pseudogene. - It does not participate in biological pathways targeted by drugs. - It should not be considered a therapeutic target, and its primary significance is as a genomic relic of ribosomal protein gene duplication events. If structured information is needed for the related functional gene, refer to RPL30 (Ribosomal protein L30), which is a genuine ribosomal protein gene involved in protein synthesis, but not RPL30P2[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L30 pseudogene 2 (RPL30P2).